6 ms·
According to Wikipedia the comprehensive metabolic panel is a series of 14 tests: https://en.m.wikipedia.org/wiki/Comprehensive_metabolic_panel https://en.m.wi
by melling 11y ago
According to Wikipedia the comprehensive metabolic panel is a series of 14 tests:
https://en.m.wikipedia.org/wiki/Comprehensive_metabolic_panel https://en.m.wikipedia.org/wiki/Comprehensive_metabolic_pane...
"The tests are performed on machines based on the AutoAnalyzer invented in 1957."
Is there some reason that this should cost $300 58 years later? No Moore's Law in medicine?
- CamperBob2 11y ago"The tests are performed on machines based on the AutoAnalyzer invented in 1957." That's like saying that modern PCs are based on the IBM 360 architecture from 1964. To the extent it's true, it's true in a way that makes sense only to a tech-illiterate journalist.
- danso 11y agoThat quote comes from the Wikipedia article, not the WSJ.
- CamperBob2 11y agoThat doesn't make it any more meaningful. It's a ridiculous thing to say in any context.
- danso 11y agoNo argument there...just wanted to point out that the author of the submitted article didn't make such a claim, as that would cast some doubt about the assertions of the reporting.
- CamperBob2 11y agoTrue, for some reason I read his post as both linking to Wikipedia and quoting from the original article; my bad.
- rgbrenner 11y agoit's not possible to determine if that cost has increased or decreased using a single data point.
- tgokh 11y agoIt doesn't. You can go online and pay less than $30 for these tests, then drive to one of Quest or LabCorp's locations to get the blood drawn. I suspect that what UCSF is charging Theranos includes a substantial markup on the actual test cost + overhead.
- mnglkhn2 11y agoUCSF does not operate at the scale LabCorp and Quest do and hence cannot benefit from economies of scale. Also, Theranos might not have the option to outsource to one of the big two, and hence operates with the smaller entity, which charges them a "special" fee, given the "special" situation. In other words: it is a price dictated by business decisions and not based on economics. PS: The WSJ article is more of an effort by Walgreens to do damage control and try to distance themselves from Theranos. Most likely their brand took a hit from this association. (also, it looks like Walgreens loaned Theranos $50mil for this deal)